Larimar Therapeutics Inc. (LRMR)
Market Closed
17 Jul, 20:00
$
3. 70
+0.03
+0.8174%
$
318.35M Market Cap
- P/E Ratio
- Div Yield
1.39M Volume
-1.23 Eps
$ 3.67
Previous Close 
Want to track LRMR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Larimar Therapeutics Inc. (LRMR) Statistics
Valuation metrics
Market Cap 318.35M
Enterprise value 142.5M
Trailing P/E (ttm) -1.76
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) -
Price/Book (mrq) 1.99
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.86
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.38M
Average volume (90 days) 2.3M
Price summary
52-Week low 2.71
52-Week high 6.42
Beta -
50-Day moving average 3.48
200-Day moving average 4.06
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:12
Last split Date 29 May 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.8%
Return on equity -1.34%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.35
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 4.29%
Book value per share (mrq) 1.86
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
